胺基与电治疗治疗抑郁症:临床医生的指南
Sophie I Elliott1, Rachel B Katz1, Robert B Ostroff1
1Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut (all authors); Interventional Psychiatry Services, Yale Psychiatry Hospital, New Haven, Connecticut (Katz, Ostroff, Ansari, Holmes, Sanacora).
Focus (American Psychiatric Publishing)
|April 16, 2025
概括
电疗法 (ECT) 和胺在严重抑郁症中表现出类似的疗效,但患者特异性因素是关键因素. 需要进一步的研究来确定治疗耐药性抑郁症的最佳治疗选择.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 公共卫生 公共卫生
背景情况:
- 大型抑郁症 (MDD) 构成了全球重大健康挑战.
- 药物治疗对于中度至重度的MDD通常是不够的,导致治疗耐药性抑郁症 (TRD).
- 电疗法 (ECT) 是严重TRD的既定标准,但胺是一种新兴的替代方案.
研究的目的:
- 为了比较胺和ECT对治疗耐药抑郁症的疗效.
- 分析有关胺和ECT优越性的现有研究中的差异.
- 以指导临床医生根据患者特定因素选择最佳治疗方法.
主要方法:
- 两项大型非劣等性试验和三个比较胺和ECT的元分析的审查.
- 分析患者选择标准,结果测量,治疗交付和现场体验变化.
- 对两种治疗方法的风险-益处概况和患者特异性考虑的检查.
主要成果:
- 证据支持胺和ECT对TRD的疗效.
- 关于一种治疗方法对另一种治疗方法的优越性,存在矛盾的发现.
- 差异可能源于研究方法和患者群体的变化.
结论:
- 胺是一种有希望的替代ECT治疗严重的治疗耐药性抑郁症.
- 最佳的治疗选择需要仔细考虑个体患者的因素,风险和益处.
- 需要进一步的研究来澄清比较有效性,并指导临床决策.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
28.1K
09:07Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
11.9K
相关概念视频
01:30Electroconvulsive Therapy
18
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
18
01:23Antidepressant Drugs: MAOIs and Other Agents
164
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
164